Dr. McInnes is a nationally recognized expert in psychiatry, mood and anxiety disorders, ketamine treatment and psychedelic medicine. She is currently Vice President of Medical Affairs at Osmind, the leading software solution for ketamine clinics and treatment-resistant mental health. She founded and served as Medical Director for Kaiser Permanente's ketamine infusion therapy program for a number of years. She was an Associate Professor of Psychiatry at Mount Sinai School of Medicine for 8 years where she ran a lab in psychiatric genetics, and is currently a clinical professor at UCSF. In her current clinical practice, she focuses on ketamine-assisted psychotherapy. Dr. McInnes received Bachelor’s and Master’s degrees from Stanford University and her MD from Columbia University. She completed psychiatry residency at UCSF and research at the VA Research Fellowship and Howard Hughes Physician Research Fellowship in Psychiatric Genetics at UCSF.